CO2019008176A2 - Compuestos medicinales y suplementos nutricionales - Google Patents
Compuestos medicinales y suplementos nutricionalesInfo
- Publication number
- CO2019008176A2 CO2019008176A2 CONC2019/0008176A CO2019008176A CO2019008176A2 CO 2019008176 A2 CO2019008176 A2 CO 2019008176A2 CO 2019008176 A CO2019008176 A CO 2019008176A CO 2019008176 A2 CO2019008176 A2 CO 2019008176A2
- Authority
- CO
- Colombia
- Prior art keywords
- nutritional supplements
- medicinal compounds
- carriers
- various
- carrier
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 229930003827 cannabinoid Natural products 0.000 abstract 2
- 239000003557 cannabinoid Substances 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen compuestos medicinales o suplementos nutricionales de cannabinoide sintético en diversas combinaciones de portador. Los portadores pueden incluir aminoácidos grasos N-acilados, potenciadores de penetración y/o diversos otros portadores favorables. Las combinaciones de portador/composición de cannabinoide sintético pueden crear beneficios de administración.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762441908P | 2017-01-03 | 2017-01-03 | |
PCT/US2018/012261 WO2018129097A1 (en) | 2017-01-03 | 2018-01-03 | Medicinal compounds and nutritional supplements |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2019008176A2 true CO2019008176A2 (es) | 2019-08-20 |
Family
ID=62790943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2019/0008176A CO2019008176A2 (es) | 2017-01-03 | 2019-07-29 | Compuestos medicinales y suplementos nutricionales |
Country Status (14)
Country | Link |
---|---|
US (2) | US20190336472A1 (es) |
EP (1) | EP3565539A4 (es) |
JP (3) | JP7281815B2 (es) |
KR (1) | KR20190103302A (es) |
CN (1) | CN110121337A (es) |
AU (2) | AU2018206564B2 (es) |
BR (1) | BR112019013743A2 (es) |
CA (1) | CA3049226A1 (es) |
CL (1) | CL2019001832A1 (es) |
CO (1) | CO2019008176A2 (es) |
EA (1) | EA201991641A1 (es) |
IL (1) | IL267831A (es) |
MX (1) | MX2019007968A (es) |
WO (1) | WO2018129097A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11180781B2 (en) * | 2016-08-21 | 2021-11-23 | Insectergy, Llc | Biosynthetic cannabinoid production methods |
WO2017185038A1 (en) | 2016-04-22 | 2017-10-26 | Receptor Life Sciences | Fast-acting plant-based medicinal compounds and nutritional supplements |
EA201892396A1 (ru) | 2016-12-02 | 2019-04-30 | Ресептор Лайф Сайенсиз, Инк. | Быстродействующие растительные лекарственные соединения и биологически активные добавки |
US20190336472A1 (en) | 2017-01-03 | 2019-11-07 | Receptor Holdings, Inc. | Medicinal compounds and nutritional supplements |
WO2019144221A1 (en) * | 2018-01-29 | 2019-08-01 | Solantech Inc. | Methods of treating and/or preventing bedsores using nabilone |
KR20210116432A (ko) * | 2018-10-10 | 2021-09-27 | 틸레이, 인크. | 화학요법으로 유발된 메스꺼움 및 구토 치료를 위한 방법 및 제형 |
AR117118A1 (es) * | 2018-11-19 | 2021-07-14 | Receptor Holdings Inc | Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides |
US11622956B1 (en) | 2019-06-26 | 2023-04-11 | RCR BioPharma | Compound and method for treating diseases and disorders |
KR20220054331A (ko) | 2019-08-30 | 2022-05-02 | 삭소 | 로딩된 과립, 이의 제조 방법 및 이의 용도 |
CN113040337B (zh) * | 2021-04-22 | 2022-12-09 | 四川大学 | 一种熏肉制品及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008490A1 (en) | 1996-09-01 | 1998-03-05 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
EP1461031B1 (en) * | 2001-11-29 | 2016-06-29 | Emisphere Technologies, Inc. | Formulations for oral administration of cromolyn sodium |
CN101541299B (zh) | 2006-09-15 | 2013-04-17 | 艾可制药有限公司 | 供舌下、口含或口服施用的不溶于水的药物活性物质的剂量单位 |
CA2817177A1 (en) * | 2010-11-25 | 2012-05-31 | Aop Orphan Pharmaceuticals Ag | Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin |
EP2747563A4 (en) * | 2011-08-26 | 2015-06-24 | Aegis Therapeutics Llc | COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS |
CA2845443A1 (en) * | 2014-03-04 | 2015-09-04 | Pharmascience Inc. | Orally disintegrating tablet of nabilone and method of manufacturing |
WO2017185038A1 (en) * | 2016-04-22 | 2017-10-26 | Receptor Life Sciences | Fast-acting plant-based medicinal compounds and nutritional supplements |
US20190336472A1 (en) | 2017-01-03 | 2019-11-07 | Receptor Holdings, Inc. | Medicinal compounds and nutritional supplements |
-
2018
- 2018-01-03 US US16/474,480 patent/US20190336472A1/en not_active Abandoned
- 2018-01-03 EP EP18736204.1A patent/EP3565539A4/en active Pending
- 2018-01-03 AU AU2018206564A patent/AU2018206564B2/en active Active
- 2018-01-03 WO PCT/US2018/012261 patent/WO2018129097A1/en unknown
- 2018-01-03 CN CN201880005658.8A patent/CN110121337A/zh active Pending
- 2018-01-03 KR KR1020197022846A patent/KR20190103302A/ko not_active Application Discontinuation
- 2018-01-03 CA CA3049226A patent/CA3049226A1/en active Pending
- 2018-01-03 MX MX2019007968A patent/MX2019007968A/es unknown
- 2018-01-03 BR BR112019013743A patent/BR112019013743A2/pt not_active Application Discontinuation
- 2018-01-03 EA EA201991641A patent/EA201991641A1/ru unknown
- 2018-01-03 JP JP2019536222A patent/JP7281815B2/ja active Active
-
2019
- 2019-07-02 CL CL2019001832A patent/CL2019001832A1/es unknown
- 2019-07-03 IL IL267831A patent/IL267831A/en unknown
- 2019-07-29 CO CONC2019/0008176A patent/CO2019008176A2/es unknown
-
2022
- 2022-06-07 US US17/834,798 patent/US20230293479A1/en active Pending
-
2023
- 2023-02-10 JP JP2023018922A patent/JP7466238B2/ja active Active
-
2024
- 2024-02-20 AU AU2024201078A patent/AU2024201078A1/en active Pending
- 2024-03-25 JP JP2024047771A patent/JP2024075724A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CL2019001832A1 (es) | 2020-01-31 |
AU2018206564B2 (en) | 2023-12-07 |
AU2024201078A1 (en) | 2024-03-07 |
EA201991641A1 (ru) | 2020-03-10 |
JP2023071697A (ja) | 2023-05-23 |
MX2019007968A (es) | 2019-12-05 |
WO2018129097A1 (en) | 2018-07-12 |
EP3565539A4 (en) | 2020-08-12 |
JP2020503357A (ja) | 2020-01-30 |
CN110121337A (zh) | 2019-08-13 |
US20190336472A1 (en) | 2019-11-07 |
CA3049226A1 (en) | 2018-07-12 |
IL267831A (en) | 2019-09-26 |
JP7281815B2 (ja) | 2023-05-26 |
US20230293479A1 (en) | 2023-09-21 |
JP2024075724A (ja) | 2024-06-04 |
JP7466238B2 (ja) | 2024-04-12 |
EP3565539A1 (en) | 2019-11-13 |
KR20190103302A (ko) | 2019-09-04 |
AU2018206564A1 (en) | 2019-08-15 |
BR112019013743A2 (pt) | 2020-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019008176A2 (es) | Compuestos medicinales y suplementos nutricionales | |
CO2018011299A2 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción | |
CO2019005565A2 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción | |
CO2020005349A2 (es) | Composiciones de hierbas con mejor biodisponibilidad | |
CL2023000973A1 (es) | Inhibidores de ras | |
CL2023000974A1 (es) | Inhibidores de ras | |
CO2019009258A2 (es) | Administración rápida y controlada de composiciones con efectos séquito restaurados | |
UY37920A (es) | Formulaciones cannabinoides sintéticas y a base de plantas de inicio rápido y acción prolongada | |
BR112018012707A2 (pt) | inibidores da interação de menin-mll | |
BR112015019064A8 (pt) | uso de uma composição compreendendo nanopartículas compreendendo paclitaxel e uma albumina para o tratamento de melanoma e kit | |
CL2019002605A1 (es) | Formulaciones que contienen proteínas de unión pd-1 y métodos de fabricación de las mismas. | |
AR101414A1 (es) | Derivados de pirrolidinona como inhibidores de metap-2 | |
CL2020001464A1 (es) | Péptidos antimicrobianos y métodos para usarlos. | |
DOP2018000034A (es) | Combinaciones de un anticuerpo ox40 y un modulador de tlr4 y usos de las mismas | |
UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
EA202190633A1 (ru) | Лекарственные формы для применения в педиатрии, способы получения и применения | |
ECSP15009928A (es) | Producto de pienso y/o ingrediente de pienso | |
EA201892376A1 (ru) | Комбинированный состав трех противовирусных соединений | |
CO2018011420A2 (es) | Formulaciones líquidas de fosfaplatino | |
AR100204A1 (es) | Compuesto de 1,1-adipoilbis(pirrolidina-2-carboxilato), composición farmacéutica que lo comprende y conjunto de partes que los incluye | |
EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
AR105728A1 (es) | Lisobactina para su uso en el tratamiento de la mastitis bovina | |
CL2018003514A1 (es) | Péptidos para la inhibición de infecciones causadas por un parásito. | |
UA112269U (xx) | Люмінесцентний матеріал | |
UA108571U (uk) | Препарат незамінних жирних кислот "ліпосан" |